Li Yan

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Epidemiology of early vs late recurrence among women with early stage estrogen receptor–positive breast cancer in the Pathways Study”.

Epidemiology of early vs late recurrence among women with early stage estrogen receptor–positive breast cancer in the Pathways Study

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae128

N/A

0.360DataRank · unranked

10 citations

Haiyang Sheng, Emily C. Liang, Shipra Gandhi, Marilyn L. Kwan, Isaac J. Ergas +8 more

miR-150 expression in breast cancer attracts and activates immune cells, and is associated with better patient outcome.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.570

N/A

0DataRank · unranked

3 citations

Aparna Maiti, Rongrong Wu, Yoshihisa Tokumaru, Vijayashree Murthy, Li Yan +5 more

Establishment of a novel BRCAness score that predicts response to PARP inhibitors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.549

N/A

0DataRank · unranked

0 citations

Shipra Gandhi, Rongrong Wu, Mariko Asaoka, Li Yan, Akimitsu Yamada +6 more

RAD51 High-Expressed Hepatocellular Carcinomas Are Associated With High Cell Proliferation

Journal of Surgical Research(2024)10.1016/j.jss.2024.07.046

N/A

0DataRank · unranked

7 citations

Li Yan, Nan An, Kohei Chida, Wanqing Tian, Masanori Oshi +2 more